Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kinlay

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
International Journal of Cardiology|November 23, 2011
Asymptomatic embolized HELEX PFO closure device: catheter based retrieval and value of routine echocardiography the following dayGeorge V Moukarbel, Danai Kitkungvan, Muhamed Adeeb Safiia, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 8, 2025
Long-term risk of adverse limb outcomes in older patients after endovascular femoral artery revascularization: The Boston femoral artery endovascular revascularization outcomes (Boston FAROUT) studyJay Khambhati, Piotr Sobieszczyk, Andrew C Eisenhauer, et al.
European Heart Journal Open|January 21, 2026
Relationship of cancer and dual antiplatelet duration to long-term risk of ischaemic and bleeding outcomes after percutaneous coronary interventionRamael Ohiomoba, Edwin Mandieka, Melissa M Young, et al.
Circulation. Genomic and Precision Medicine|April 22, 2026
Genome-Wide Association Study of Chronic Venous Insufficiency and Lymphedema in the Million Veteran ProgramGina M Peloso, Nimish Adhikari, Melissa M Young, et al.
Vascular Medicine (London, England)|May 22, 2023
Patient and limb outcomes 10 years after endovascular revascularization of the superficial femoral artery for peripheral artery disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) studyScott Kinlay, Piotr Sobieszczyk, Andrew C Eisenhauer, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|November 11, 2024
Long-Term Adverse Limb Events After Femoral Artery Endovascular Revascularization: The Boston FAROUT StudyEdwin Mandieka, Ramael Ohiomoba, Piotr Sobieszczyk, et al.
Hypertension (Dallas, Tex. : 1979)|May 21, 2003
Endothelin-1 and vascular tone in subjects with atherogenic risk factorsAnju Nohria, Leslie Garrett, Wendy Johnson, et al.
Critical Pathways in Cardiology|February 17, 2012
Protocol for vasoreactivity testing with epoprostenol in pulmonary hypertensionBradley A Maron, Deepak L Bhatt, Martha Nykiel, et al.
Circulation. Heart Failure|October 8, 2009
Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosisEric Larose, Dominik Behrendt, Scott Kinlay, et al.
Platelets|August 16, 2002
Clopidogrel inhibits shear-induced platelet functionJames L Orford, Scott Kinlay, Mark R Adams, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
International Journal of Cardiology|November 23, 2011
Asymptomatic embolized HELEX PFO closure device: catheter based retrieval and value of routine echocardiography the following dayGeorge V Moukarbel, Danai Kitkungvan, Muhamed Adeeb Safiia, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 8, 2025
Long-term risk of adverse limb outcomes in older patients after endovascular femoral artery revascularization: The Boston femoral artery endovascular revascularization outcomes (Boston FAROUT) studyJay Khambhati, Piotr Sobieszczyk, Andrew C Eisenhauer, et al.
European Heart Journal Open|January 21, 2026
Relationship of cancer and dual antiplatelet duration to long-term risk of ischaemic and bleeding outcomes after percutaneous coronary interventionRamael Ohiomoba, Edwin Mandieka, Melissa M Young, et al.
Circulation. Genomic and Precision Medicine|April 22, 2026
Genome-Wide Association Study of Chronic Venous Insufficiency and Lymphedema in the Million Veteran ProgramGina M Peloso, Nimish Adhikari, Melissa M Young, et al.
Vascular Medicine (London, England)|May 22, 2023
Patient and limb outcomes 10 years after endovascular revascularization of the superficial femoral artery for peripheral artery disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) studyScott Kinlay, Piotr Sobieszczyk, Andrew C Eisenhauer, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|November 11, 2024
Long-Term Adverse Limb Events After Femoral Artery Endovascular Revascularization: The Boston FAROUT StudyEdwin Mandieka, Ramael Ohiomoba, Piotr Sobieszczyk, et al.
Hypertension (Dallas, Tex. : 1979)|May 21, 2003
Endothelin-1 and vascular tone in subjects with atherogenic risk factorsAnju Nohria, Leslie Garrett, Wendy Johnson, et al.
Critical Pathways in Cardiology|February 17, 2012
Protocol for vasoreactivity testing with epoprostenol in pulmonary hypertensionBradley A Maron, Deepak L Bhatt, Martha Nykiel, et al.
Circulation. Heart Failure|October 8, 2009
Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosisEric Larose, Dominik Behrendt, Scott Kinlay, et al.
Platelets|August 16, 2002
Clopidogrel inhibits shear-induced platelet functionJames L Orford, Scott Kinlay, Mark R Adams, et al.
Pageof 13